Details for New Drug Application (NDA): 072691
✉ Email this page to a colleague
NDA 072691 describes AMOXAPINE, which is a drug marketed by Chartwell Rx, Watson Labs, and Watson Pharms Teva, and is included in six NDAs. It is available from two suppliers. Additional details are available on the AMOXAPINE profile page.
The generic ingredient in AMOXAPINE is amoxapine. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
The generic ingredient in AMOXAPINE is amoxapine. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
Summary for 072691
| Tradename: | AMOXAPINE |
| Applicant: | Watson Labs |
| Ingredient: | amoxapine |
| Patents: | 0 |
Suppliers and Packaging for NDA: 072691
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMOXAPINE | amoxapine | TABLET;ORAL | 072691 | ANDA | Actavis Pharma, Inc. | 0591-5713 | 0591-5713-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5713-01) |
| AMOXAPINE | amoxapine | TABLET;ORAL | 072691 | ANDA | Actavis Pharma, Inc. | 0591-5714 | 0591-5714-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5714-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
| Approval Date: | Aug 28, 1992 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Aug 28, 1992 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Aug 28, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
